China’s securities regulator has reportedly told investment banks to pause new initial public offerings and temporarily restrict large share sales by existing shareholders as authorities seek to ease pressure on the country’s stock market. The Financial Times, citing three people familiar with the discussions, reported that the China Securities Regulatory Commission had held meetings with investment banks and issued informal “window guidance.” The reported instruction is not the same as a publicly announced formal ban. Reuters later reported the development but said it could not independently verify the Financial Times account. Chinese financial regulators did not immediately respond to Reuters’ request for comment. For now, the most accurate description is that regulators have reportedly asked banks to hold off on certain transactions, rather than that a formal nationwide IPO prohibition has been confirmed.
The report emerged after a sharp decline in Chinese equities. The Financial Times and Reuters said the CSI 300 index fell 8.5% in October, its worst monthly performance in more than a decade. The index was down 15% over the past 12 weeks, according to a Reuters market report on October 30. The FT also reported that IPO fundraising in China had exceeded 292 billion yuan, the highest level since 2023. A pause in new listings could reduce the amount of capital diverted from existing shares into newly issued stock. But it could also interrupt an IPO market that had recently regained momentum. The FT cited memory-chip maker Yangtze Memory Technologies Corp. as a company that had been expected to list, suggesting that the reported guidance could delay plans for some large issuers.
The IPO report came as regulators were introducing additional tools to support equities. Reuters, Bloomberg and City News Service reported that the People’s Bank of China and financial regulators had revived market-support facilities, including a swap program for securities firms, funds and insurers, as well as a relending program that helps finance share buybacks by listed companies. Business Insider reported that 31 securities firms and fund managers had applied for more than 100 billion yuan in liquidity support. The central bank also reduced the interest rate on its share-buyback relending facility from 1.25% to 1%. These measures are intended to make funding available for institutional stock purchases and corporate buybacks. They do not, however, guarantee a change in investor sentiment.
Market trading suggested that the policy support had not produced a sustained rebound. Reuters reported that technology shares remained under pressure after the measures were announced. The CSI 300 and Shanghai Composite indexes were down more than 1% early on Tuesday before trimming their losses. A Bloomberg report published by The Edge said the technology-heavy STAR 50 index fell nearly 4% on Tuesday, erasing gains made in the previous session on expectations of policy support. Barron’s warned that the downturn could slow China’s IPO market and limit the ability of technology companies to raise capital through public listings. Earlier reporting by CNN linked the broader market weakness to soft consumer spending, concerns about artificial-intelligence investment and the prolonged property downturn.
Analysts say restricting the supply of shares and making buyback funding easier may help limit near-term selling pressure, but neither measure automatically improves corporate earnings, household consumption or the property market. Business Insider cited research analysts who described the latest measures as an attempt to put a floor under markets rather than trigger another broad rally. Reuters Breakingviews also argued that a lasting recovery will depend on better corporate earnings and broader economic policy. If the reported IPO pause lasts, it could affect companies seeking capital, investment banks that underwrite listings and technology firms planning expansion. Because the reported suspension is based largely on anonymous sources and media accounts, its scope, duration and application to other forms of equity financing remain unclear pending further clarification from regulators.